For example, a retrospective cohort study reported that adults receiving semaglutide (Wegovy/Ozempic, Novo Nordisk) as a type 2 diabetes or obesity medication had lower risk for suicidal ideation than those using a drug that is not a GLP-1 receptor agonist
Use for kidney protection in people without diabetes is investigational.All healthcare decisions should be made in consultation with qualified medical professionals.
The rise of GLP-1 medications prescribed via telehealth, including tirzepatide (Mounjaro, Zepbound), semaglutide (Ozempic, Wegovy) and liraglutide (Saxenda), has produced positive results for many individuals
By activating GLP-1 receptors in the brain, this medication significantly reduces hunger and enhances feelings of fullness, leading to decreased calorie intake
Trust our experts to guide you confidently on your path to sustainable weight management.